Overview

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in African American subjects with hypercholesterolemia.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Atorvastatin
Atorvastatin Calcium
Rosuvastatin Calcium